Aug 19, 2026 · 10 min
Moderna rallies as Treasuries and retailers reshape the close
Closing Bell: Moderna Surges, Estee Lauder Soars, TJ Maxx Declines
The episode connects company-specific surprises with shifting bond-market policy and a broader debate over how cities adapt to rapid growth.
- 1Moderna surged on encouraging personalized cancer-vaccine trial results developed with Merck’s Keytruda.
- 2TJX and Viking Holdings fell as comparable sales and European river-cruise conditions raised concerns.
- 3Long-term Treasury yields dropped after Scott Bessent doubled the Treasury buyback cap, with liquidity implications.
Don't miss
Moderna’s sharp rise after encouraging personalized cancer-vaccine trial results provides the episode’s clearest link between medical progress and market reaction.
The brief
Moderna led the gainers after encouraging results for a personalized cancer vaccine developed with Merck’s Keytruda, while Estée Lauder rose after beating expectations.
The decliners showed a different pressure point: TJX reported weaker comparable sales in MarMaxx, while Viking Holdings faced concern over low European river levels.
Long-term Treasury yields fell sharply, including 20-year and 30-year maturities, as Treasury Secretary Scott Bessent doubled the buyback cap and raised liquidity questions.
The episode closes by turning from markets to smart cities, examining how AI and long-term planning can help urban systems absorb rapid population growth, including in Dubai.
What was said on this episode
13 statements · 8 positive · 2 negative · 3 neutral
Moderna’s personalized cancer vaccine with Keytruda reduced melanoma recurrence in a late-stage trial.
“a personalized cancer vaccine combined with partner Merck's Keytruda helped cut the recurrence of melanoma in a large late-stage trial”
Listen at 1:17
Messenger RNA technology will achieve a successful second act.
“messenger RNA technology will have a successful second act”
Listen at 1:28
Moderna and Merck will discuss regulatory filing and present trial data.
“the companies will discuss filing for approval with regulators and present the data in an upcoming medical meeting”
Listen at 1:32
Estée Lauder’s results beat estimates and ended three annual revenue declines.
“shares jumping after the results beat estimates and ended a run of three straight declines in annual revenue”
Listen at 2:16
Estée Lauder reported $3.6 billion revenue and 5% organic sales growth.
“Company reported revenue of $3.6 billion in its fiscal fourth quarter, and organic sales growth accelerated to 5%”
Listen at 2:21
Twist Bioscience shares rose 22% during the session.
“Twist Bioscience, you can see up 22% in today's session”
Listen at 2:48
TJX’s MarMaxx second-quarter comparable sales missed estimates.
“The clothing retailer reported second quarter comp sales for its MarMax segment, which missed estimates.”
Listen at 3:53
Viking management is addressing concerns about low Danube and Rhine water levels.
“Management of the river cruise company trying to soothe investor concerns today about the impact of low water levels in the Danube and Rhine rivers.”
Listen at 5:06
WhiteFiber priced $270 million in senior notes to build AI infrastructure.
“They priced a private placement, $270 million of a senior note offering to build out AI infrastructure.”
Listen at 6:04
Scott Bessent doubled the Treasury buyback cap from $2 billion to $4 billion.
“Scott Besson lifting the Treasury's buyback cap, doubling it, I should say, from $2 billion to $4 billion.”
Listen at 6:48
AI will compress processes and increase speed in smart-city systems.
“AI will allow in the smart city space to compress a lot of things. The speed will change.”
Listen at 7:51
Dubai responded very well to its sudden population increase.
“I think they reacted very well to it.”
Listen at 8:17
Dubai has a long-term urban planning vision uncommon worldwide.
“They have a long-term urban planning vision, which again doesn't happen everywhere in the world.”
Listen at 8:19
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Featuring
Romaine Bostick
S&P 500Listen to the full episode and explore every guest, topic, and moment on PodLume.